National guidelines recommend that older patients with heavy smoking histories get screened each year for lung cancer. Because half of patients eligible for this screening continue to smoke, and stopping smoking has been shown to help these patients live longer and better, lung cancer screening programs are required to offer smoking cessation services. However, the best way to help people stop smoking in the context of lung cancer screening is unknown. Importantly, there is very little evidence about how to reduce risks for lung cancer and other tobacco-related illnesses among underserved patients, including those who are black, Hispanic, live in rural areas, or have low income or education. This clinical trial will test the effectiveness of four approaches to help patients quit smoking at the time of lung cancer screening. By comparing four different strategies which differ in the types and number of barriers to quitting that they seek to overcome, the goal of this trial is to understand which interventions work best to help underserved patients quit smoking. This study will also evaluate if different interventions work better for specific groups, for example for people of different races, ethnicities, incomes, and degrees of tobacco dependence.
Patient-Centered Outcomes Research Institute (PCORI)